Moyamoya disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who diagnosed with moyamoya disease; 2. Aged 18 to 65 years; 3. The onset symptoms manifested as ischemic symptoms (TIA or stroke) or atypical symptoms (headache, epilepsy or asymptomatic); 4. Able to receive the necessary imaging examination; 5. Patients who pre-agreed to the study.
Exclusion criteria
Exclusion criteria: 1. Prior cerebral hemorrhage history; 2. Other brain or cerebrovascular disease; 3. Previous history of revascularization surgery; 4. Dependent (mRS > 2); 5. Receive other type of revascularization surgery; 6. Peripheral blood vessel disease (especially subclavian arterial and upper limb artery stenosis or occlusion).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cerebrovascular events (ischemic stroke, cerebral hemorrhage, transient neurological deficits) within 30 days post-surgery;All death or dependent (mRS > 2) within 30 days post-surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| The severity of the ischemic stroke after surgery;Number of patients occurred re-stroke at Follow-up Period;Number of patients dependent or death at follow-up period;Number of patients with improved neurological function at follow-up period;Perfusion status of patients at follow-up period;Number of patients with any side effects of remote ischemic preconditioning (RIPC) treatment;The presence of =1 new brain lesions on DWI within 48 hours after EDAS; | — |
Countries
China
Contacts
Beijing Tiantan Hospital, Capital Medical University